---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-071656"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:33:52.406595+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Priveterra Acquisition receives Nasdaq deficiency notice for MVLS below $35M; adjourns special meeting

## Summary
- Nasdaq notified that MVLS was below $35M minimum for 30 consecutive business days; 180-day cure period ends Dec 11, 2023.
- Special meeting for AEON Biopharma business combination adjourned from June 15 to June 21, 2023 for more stockholder engagement.
- Company may consider options to regain compliance with MVLS requirement; securities continue trading during cure period.
- Proxy supplement filed; no change to record date, redemption deadline, or other proposals.

## SEC filing metadata
- accession: 0001104659-23-071656
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000110465923071656/0001104659-23-071656-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000110465923071656/tm2318880d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-071656
- JSON: https://secwatch.observer/filing/0001104659-23-071656.json
- Plain text: https://secwatch.observer/filing/0001104659-23-071656.txt

## Key facts
- Listing & Compliance Notices
  AEON Biopharma, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2), 5810(c)(3)(C)
  source text: June 13, 2023, the Company received a notification letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that for the last 30 consecutive business days preceding the date of the Notice, the Company’s Market Value of Listed Securities (“MVLS”) has been below the minimum of $35,000,000 required for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days, or until December 11, 2023, to regain compliance with the MVLS Requirement (the “Co
  evidence_url: https://www.sec.gov/Archives/edgar/data/1837607/000110465923071656/0001104659-23-071656-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.